| Gene symbol | CEACAM5 | Synonyms | CD66e, CEA | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19q13.2 | dbXrefs | |
| Description | CEA cell adhesion molecule 5 | ||||
| GTO ID | GTC3587 |
| Trial ID | NCT06043466 |
| Disease | Colorectal Cancer | Esophagus Cancer | Gastric Cancer | Pancreas Cancer | Non-Small Cell Lung Cancer | Breast Cancer | Bile Duct Cancer |
| Altered gene | CEA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CEA CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Phase I Clinical Study of Chimeric Antigen Receptor T Cells (C-13-60) in the Treatment of Carcinoembryonic Antigen (CEA) Positive Advanced Malignant Solid Tumors |
| Year | 2023 |
| Country | China |
| Company sponsor | Chongqing Precision Biotech Co., Ltd |
| Other ID(s) | PB06 |
| Cohort 1 | |||||||||||||
|
|||||||||||||